News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Headache and Migraine

Latest News

Latest Videos

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

Edasalonexent Promising for DMD, nVNS May Resolve Vestibular Migraine Symptoms, NIA Backs New Alzheimer Disease Research Centers

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 Score

Richard Lipton, MD: Interpreting Eptinezumab's Impact on HIT-6 Score

Paul Durham, PhD: A Combination Approach With nVNS in Migraine

Paul Durham, PhD: A Combination Approach With nVNS in Migraine

Paul Durham, PhD: Noninvasive Vagus Nerve Stimulation

Paul Durham, PhD: Noninvasive Vagus Nerve Stimulation

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

FDA Rejects Duchenne Muscular Dystrophy Drug Golodirsen, Pfizer Recalls Acute Migraine Treatment Relpax, Alzheimer Disease Update

Rebecca Stainman, MD: Identifying, Addressing Physician Burnout

Rebecca Stainman, MD: Identifying, Addressing Physician Burnout

Nina Riggins, MD, PhD: Predicting Outcomes of Botox Treatment in Chronic Migraine

Nina Riggins, MD, PhD: Predicting Outcomes of Botox Treatment in Chronic Migraine

Jelena Pavlovic, MD, PhD: Perimenstrual-Related Migraine

Jelena Pavlovic, MD, PhD: Perimenstrual-Related Migraine

Alon Ironi: Nerivio Migra Reduces Excess Medication Use in Migraine

Alon Ironi: Nerivio Migra Reduces Excess Medication Use in Migraine

CME Content

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

In-Person + Virtual Event

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

November 21, 2025

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

Patient, Provider, and Caregiver Connection™: Pediatric Myasthenia Gravis—Current Treatment and Emerging Concepts

John F. Brandsema, MD; Abigail N. Schwaede, MD; Samuel J. Mackenzie, MD, PhD

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

Mind Moments™: Optimizing Management for Patients with Generalized Myasthenia Gravis

James F. Howard Jr, MD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations

John Brandsema, MD; Neelam Goyal, MD

Identifying and Treating CIDP in the Modern Era

Identifying and Treating CIDP in the Modern Era

Jeffrey A. Allen, MD; Karissa L. Gable, MD

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

Cases and Conversations™: Little Voices, Big Challenges – Comprehensive Care for Pediatric Spinal Muscular Atrophy

John Brandsema, MD; Carla D. Zingariello, DO

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One

Estelamari Rodriguez, MD, MPH; Millie Das, MD; Ruham Nasany, MD

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients

Anne Chiang, MD, PhD; J. Douglas Miles, MD, PhD, FAAN; Suma Satti, MD

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Patient, Provider, and Caregiver Connection: Improving Diagnosis and Care for Adolescent Myasthenia Gravis Patients – A New Frontier

Abigail N. Schwaede, MD; Emmanuelle (Noelle) Tiongson, MD

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

A New Era in NMOSD Treatment: Optimizing Therapeutic Transitions and Reducing Patient Burden

Shamik Bhattacharyya, MD, MS, FAAN; Mirla Avila, MD; Dean Wingerchuk, MD

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

Richard Bedlack, MD, PhD

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

PER Podcast™: Best Strategies for Approaching the Diagnosis of Amyotrophic Lateral Sclerosis (ALS)

Terry Heiman-Patterson, MD

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy

Gerald Bernard Appel, MD; Ellie Kelepouris, MD, FACP, FAHA

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Patient, Provider, and Caregiver Connection: Turning a New Leaf in Acute Pain Management – How Recent Advancements Impact the Treatment Paradigm

Jeffrey Gudin, MD; Jeffrey Bettinger, PharmD

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Shining a Light on an Ultra-Rare Disease – A Closer Look at Thymidine Kinase 2 Deficiency (TK2d)

Zarazuela Zolkipli-Cunningham, MBChB, MRCP; Mary Kay Koenig, MD; Perry Shieh, MD, PhD, FAAN, FANA

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

Identifying and Treating Generalized Myasthenia Gravis in the Modern Era

James F. Howard Jr, MD, FAAN

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Addressing Unmet Needs for Patients With Spinal Muscular Atrophy—Understanding Patient Challenges and Management Approaches

Basil T. Darras, MD

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Expert Illustrations & Commentaries™: Visualizing the Role of Dystrophin Dysregulation as a Therapeutic Target in Duchenne Muscular Dystrophy and MD STARnet

Anne M. Connolly, MD, FAAN; Amy Moore, PhD

More News

This Week on NeurologyLive

ByNeurologyLive® Staff

November 2nd 2020

Here's what is coming soon to NeurologyLive.

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

ByNeurologyLive® Staff

October 31st 2020

Neurology News Network for the week ending October 31, 2020.

NeurologyLive Friday 5 — October 30, 2020

ByNeurologyLive® Staff

October 30th 2020

Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 30, 2020.

Therapies in Development for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Ubrogepant: Treatment for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Rimegepant: Treatment for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Patient Selection for Acute Migraine Therapy

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Acute Migraine Treatment Goals

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Treatment Goals for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Treating Acute Migraine in the Community Setting

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Acute Migraine Treatment: What’s Next?

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Real-World Experience With Gepants for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Gepants for Acute Migraine: Patient Management

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Gepants for Acute Migraine: Safety & Efficacy Data

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Advances in the Treatment of Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Burden of Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Jennifer Frontera, MD: Neurologic Implications of COVID-19 Infection

ByJennifer Frontera, MD

October 30th 2020

The professor of neurology at the NYU Langone Grossman School of Medicine gave her reaction to the data she and colleagues published on neurologic disorders in patients with COVID-19.

Behavioral and Lifestyle Strategies for Migraine Management

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Patient Selection for Neuromodulation Devices

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Role of Neuromodulation for Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Patient Selection of Novel Therapies for Migraine Treatment

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Intranasal DHE in Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Use of 5-HT1F Agonists in Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Acute Treatment of Migraine: Progress With Novel Medications

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Preliminary Phase 2 Data Support Therapeutic Development of Synaptic Regenerative Drug SPG302 in ALS

Dental Caries and Periodontal Disease Increase Ischemic Stroke Risk, Study Shows

Large-Scale Study Demonstrates Benefits of Early Nerivio REN Use for Migraine Treatmentne Treatment

Overviewing the Neurologic Risks Behind Electric Vehicles

Therapeutic Promise and Mechanism of DYNE-101 to Treat Myotonic Dystrophy: Doug Kerr, MD, PhD

© 2025 MJH Life Sciences^®

All rights reserved.